PMM2-congenital disorder of glycosylation (PMM2-CDG)

Neurodegenerative diseases
Pediatric diseases
Metabolic diseases

General description

Congenital disorder of glycosylation (CDG) is an inborn error of metabolism caused by deficient function of glycoproteins due to genetic mutations involved in the synthesis and modification processes of glycan chains of glycoproteins.

There are many types of CDGs, the most common of which is PMM2-CDG, which has a variety of symptoms including hypotonia, poor weight gain, psychomotor retardation, epilepsy, characteristic facial features, ophthalmologic abnormalities, skin symptoms such as fatty deposits on the buttocks and sunken nipples, pericardial effusion, and abnormal liver function.

While the typical onset of this syndrome occurs in early infancy, there have been case reports of affected young adults presenting with ovarian dysfunction, cerebellar ataxia, and psychiatric manifestations.

References

  1. Feraco, P., et al. "The shrunken, bright cerebellum: a characteristic MRI finding in congenital disorders of glycosylation type 1a." American journal of neuroradiology 33.11 (2012): 2062-2067.

Cerebellar atrophy

  • Cerebellum
    Vermis
Bilateral
Morphology
Atrophy

Cerebellar cortical hyperintensity

  • Cerebellum
    Cerebellar cortex
Symmetric
Bilateral
T2WI
Hyperintensity
FLAIR
Hyperintensity

T2WI and FLAIR hyperintensitiy observed within the cerebellar cortex are postulated to arise from microglial proliferation. Recent research has unveiled analogous imaging findings in other disorders, such as Marinesco-Sjögren syndrome, in addition to this disease entity.